The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Tryptophan metabolism: Mechanism-oriented therapy for neurological and psychiatric disorders
Open accessAbstract
Neurological and psychiatric disorders are a category of chronic diseases that are widespread and pose serious mental and physical health problems for patients. The substrates, products, and enzymes of Tryptophan metabolism all contribute to the development of neurological and psychiatric disorders. This paper deals with three metabolic pathways of tryptophan that produce a series of metabolites called tryptophan Catabolics (TRYCATs). These metabolites are involved in pathological processes such as excitotoxicity, neuroinflammation, oxidative stress, and mitochondrial damage and are closely associated with neurological and psychiatric disorders such as Alzheimer’s disease and depression. Here, we review the elements that affect how tryptophan metabolism is regulated, including inflammation and stress, exercise, vitamins, minerals, diet and gut microbes, glucocorticoids, and aging, as well as the downstream regulatory effects of tryptophan metabolism, including the regulation of glutamate (Glu), immunity, G-protein coupled receptor 35 (Gpr35), nicotinic acetylcholine receptor (nAChR), aryl hydrocarbon receptor (AhR), and dopamine (DA). In order to advance the general understanding of tryptophan metabolism in neurological and psychiatric disorders, this paper also summarizes the current situation and effective drugs of tryptophan metabolism in the treatment of neurological and psychiatric disorders and considers its future research prospects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Under inflammatory conditions, tryptophan metabolism shifts towards increased kynurenine levels, leading to an imbalance in its downstream metabolites (TRYCATs), such as quinolinic acid (QUIN) and kynurenic acid (KYNA).”
From The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders (2025) · cites this paper as [73]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhou, M., Wang, H., Zeng, X., Yin, P., Zhu, J. W., Chen, W., Li, X., Wang, L., Wang, L., Liu, Y., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30427-1 · Cited by 3,671
Self-citationGut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
Agus, A., Planchais, J., & Sokol, H. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.05.003 · Cited by 3,180 · cited 1×
“Including tryptamine, indoleacetic-3-acid (IAA), indolepropionic-3-acid (IPA), indolelactic acid (ILA), indole3-aldehyde (IAld), indoleacrylic acid (IA), indole-3acetaldehyde (IAAld), etc (35).”
Microbial tryptophan catabolites in health and disease
Roager, H. M., & Licht, T. R. (2018) · Nature Communications · doi:10.1038/s41467-018-05470-4 · Cited by 2,236
Synthesis of Serotonin by a Second Tryptophan Hydroxylase Isoform
Walther, D. J., Peter, J., Bashammakh, S., Hörtnagl, H., Voits, M., Fink, H., & Bäder, M. (2003) · Science · doi:10.1126/science.1078197 · Cited by 1,576
Kynurenines: Tryptophan’s metabolites in exercise, inflammation, and mental health
Cervenka, I., Agudelo, L. Z., & Ruas, J. L. (2017) · Science · doi:10.1126/science.aaf9794 · Cited by 1,382
Penna, G., & Adorini, L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2405 · Cited by 1,257
Rothhammer, V., & Quintana, F. J. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0125-8 · Cited by 1,197
Frumento, G., Rotondo, R., Tonetti, M., Damonte, G., Benatti, U., & Ferrara, G. B. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020121 · Cited by 1,133
Indoleamine 2,3 dioxygenase and metabolic control of immune responses
Munn, D. H., & Mellor, A. L. (2013) · Trends in Immunology · doi:10.1016/j.it.2012.10.001 · Cited by 1,037
T cell apoptosis by tryptophan catabolism
Fallarino, F., Grohmann, U., Vacca, C., Bianchi, R., Orabona, C., Spreca, A., Fioretti, M. C., & Puccetti, P. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401073 · Cited by 1,022
Hilmas, C. J., Pereira, E. F. R., Alkondon, M., Rassoulpour, A., Schwarcz, R. M., & Albuquerque, E. X. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07463.2001 · Cited by 875
Perkins, M. N., & Stone, T. W. (1982) · Brain Research · doi:10.1016/0006-8993(82)91048-4 · Cited by 849
Autism‐like behavioral phenotypes in BTBR T+tf/J mice
McFarlane, H. G., Kusek, G. K., Yang, M., Phoenix, J. L., Bolivar, V. J., & Crawley, J. N. (2008) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2007.00330.x · Cited by 812
Sharma, M. D., Baban, B., Chandler, P., Hou, D., Singh, N., Yagita∥, H., Azuma, M., Blazar, B. R., Mellor, A. L., & Munn, D. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31911 · Cited by 791
Williams, B. B., Van Benschoten, A. H., Cimermancic, P., Donia, M. S., Zimmermann, M., Taketani, M., Ishihara, A., Kashyap, P. C., Fraser, J. S., & Fischbach, M. A. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.09.001 · Cited by 732
Kynurenic Acid as a Ligand for Orphan G Protein-coupled Receptor GPR35
Wang, J., Simonavicius, N., Wu, X., Swaminath, G., Reagan, J. D., Tian, H., & Ling, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603503200 · Cited by 708
Quinolinic acid, the inescapable neurotoxin
Guillemin, G. J. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08485.x · Cited by 595
IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression
Sadik, A., Patterson, L. F. S., Öztürk, S., Mohapatra, S. R., Panitz, V., Secker, P. F., Pfänder, P., Loth, S., Salem, H., Prentzell, M. T., et al. (2020) · Cell · doi:10.1016/j.cell.2020.07.038 · Cited by 585
Patrick, R. P., & Ames, B. N. (2015) · The FASEB Journal · doi:10.1096/fj.14-268342 · Cited by 523
Mellor, A. L., Baban, B., Chandler, P., Marshall, B., Jhaver, K. G., Hansen, A. M., Koni, P. A., Iwashima, M., & Munn, D. H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.4.1652 · Cited by 457
Wirthgen, E., Hoeflich, A., Rebl, A., & Günther, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01957 · Cited by 401
Tumor-induced perturbations of cytokines and immune cell networks
Burkholder, B., Huang, R.-Y., Burgess, R., Luo, S., Jones, V. S., Zhang, W., Lv, Z., Gao, C., Wang, B.-L., Zhang, Y., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.01.004 · Cited by 372
Self-citationDeng, Y., Zhou, M., Wang, J., Yao, J., Yu, J., Liu, W., Wu, L., Wang, J., & Gao, R. (2021) · Gut Microbes · doi:10.1080/19490976.2020.1869501 · Cited by 362
Tryptophan (Trp) modulates gut homeostasis via aryl hydrocarbon receptor (AhR)
Sun, M., Ma, N., He, T., Johnston, L. J., & Ma, X. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2019.1598334 · Cited by 345
Marx, W., McGuinness, A. J., Rocks, T., Ruusunen, A. A., Cleminson, J. R., Walker, A. J., Gomes‐da‐Costa, S., Lane, M. M., Sanches, M., Díaz, A. P., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00951-9 · Cited by 339
The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans
Wichers, M., & Maes, M. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702003103 · Cited by 329
l-Kynurenine Its synthesis and possible regulatory function in brain
G�l, E. M., & Sherman, A. D. (1980) · Neurochemical Research · doi:10.1007/bf00964611 · Cited by 318
Kynurenine pathway abnormalities in Parkinson's disease
Ogawa, T., Matson, W. R., Beal, M. F., Myers, R. H., Bird, E. D., Milbury, P. E., & Saso, S. (1992) · Neurology · doi:10.1212/wnl.42.9.1702 · Cited by 317
Kynurenic Acid and Gpr35 Regulate Adipose Tissue Energy Homeostasis and Inflammation
Agudelo, L. Z., Ferreira, D. M. S., Červenka, I., Bryzgalova, G., Dadvar, S., Jannig, P. R., Pettersson-Klein, A. T., Lakshmikanth, T., Sustarsic, E. G., Porsmyr‐Palmertz, M., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.01.004 · Cited by 311
The kynurenine pathway and neurodegenerative disease
Maddison, D. C., & Giorgini, F. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.03.002 · Cited by 309
Tryptophan Metabolism as a Pharmacological Target
Modoux, M., Rolhion, N., Mani, S., & Sokol, H. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.11.006 · Cited by 290
Kynurenine and its metabolites in Alzheimer's disease patients
Gulaj, E., Pawlak, K., Bień, B., & Pawlak, D. (2010) · Advances in Medical Sciences · doi:10.2478/v10039-010-0023-6 · Cited by 289
The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders
Stone, T. W., & Darlington, L. G. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12230 · Cited by 276
Coupling of the NMDA receptor to neuroprotective and neurodestructive events
Hardingham, G. E. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371147 · Cited by 268
The kynurenine pathway in schizophrenia and bipolar disorder
Erhardt, S., Schwieler, L., Imbeault, S., & Engberg, G. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.05.020 · Cited by 265
The Kynurenine Pathway Modulates Neurodegeneration in a Drosophila Model of Huntington's Disease
Campesan, S., Green, E. W., Breda, C., Sathyasaikumar, K. V., Muchowski, P. J., Schwarcz, R. M., Kyriacou, C. P., & Giorgini, F. (2011) · Current Biology · doi:10.1016/j.cub.2011.04.028 · Cited by 261
Immune Influencers in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic Pathway
Tanaka, M., Tóth, F., Polyák, H., Szabó, Á., Mándi, Y., & Vécsei, L. (2021) · Biomedicines · doi:10.3390/biomedicines9070734 · Cited by 259
Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis
Plitman, E., Iwata, Y., Caravaggio, F., Nakajima, S., Chung, J. K., Gerretsen, P., Kim, J., Takeuchi, H., Chakravarty, M. M., Remington, G. J., et al. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw221 · Cited by 255
Impaired Kynurenine Pathway Metabolism in The Prefrontal Cortex of Individuals With Schizophrenia
Sathyasaikumar, K. V., Stachowski, E. K., Wonodi, I., Roberts, R. C., Rassoulpour, A., McMahon, R. P., & Schwarcz, R. M. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq112 · Cited by 253
Ionotropic Glutamate Receptors in Epilepsy: A Review Focusing on AMPA and NMDA Receptors
Hanada, T. (2020) · Biomolecules · doi:10.3390/biom10030464 · Cited by 252
Talos, D. M., Follett, P. L., Folkerth, R. D., Fishman, R. E., Trachtenberg, F. L., Volpe, J. J., & Jensen, F. E. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.20978 · Cited by 249
Diet and Anxiety: A Scoping Review
Aucoin, M., LaChance, L., Naidoo, U., Remy, D., Shekdar, T., Sayar, N., Cardozo, V., Rawana, T., Chan, I., & Cooley, K. (2021) · Nutrients · doi:10.3390/nu13124418 · Cited by 248
Network beyond IDO in psychiatric disorders: Revisiting neurodegeneration hypothesis
Myint, A.-M., & Kim, Y.-K. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.08.008 · Cited by 230
Badawy, A. A. ‐. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.11.015 · Cited by 228
Tan, P., Sagoo, P., Chan, C. C. W., Yates, J., Campbell, J., Beutelspacher, S. C., Foxwell, B. M. J., Lombardi, G., & George, A. J. T. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7633 · Cited by 224
Connor, T. J., Starr, N., O’Sullivan, J. B., & Harkin, A. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.06.007 · Cited by 222
Biosynthetic Manipulation of Tryptophan in Bacteria: Pathways and Mechanisms
Alkhalaf, L. M., & Ryan, K. S. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.02.005 · Cited by 206
NMDA receptor dysfunction in autism spectrum disorders
Lee, E.-J., Choi, S. Y., & Kim, E. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.10.007 · Cited by 192
Fujigaki, H., Yamamoto, Y., & Saito, K. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.01.011 · Cited by 189
Role of Kynurenine Pathway in Oxidative Stress during Neurodegenerative Disorders
Mor, A., Tankiewicz‐Kwedlo, A., Krupa, A., & Pawlak, D. (2021) · Cells · doi:10.3390/cells10071603 · Cited by 188
Late exercise reduces neuroinflammation and cognitive dysfunction after traumatic brain injury
Piao, C.-S., Stoica, B. A., Wu, J., Sabirzhanov, B. E., Zhao, Z., Cabatbat, R. M., Loane, D. J., & Faden, A. I. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.12.017 · Cited by 178
Increased neopterin production and tryptophan degradation in advanced Parkinson's disease.
Widner, B., Leblhuber, F., & Fuchs, D. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200014 · Cited by 171
Convergent Mechanisms Underlying Rapid Antidepressant Action
Zanos, P., Thompson, S. M., Duman, R. S., Zarate, C. A., & Gould, T. D. (2018) · CNS Drugs · doi:10.1007/s40263-018-0492-x · Cited by 171
Tryptophan metabolism: entering the field of aging and age-related pathologies
van der Goot, A. T., & Nollen, E. A. A. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.02.007 · Cited by 166
McGovern, J. L., Nguyen, D. X., Notley, C. A., Mauri, C., Isenberg, D. A., & Ehrenstein, M. R. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34565 · Cited by 163
Serotonin – Kynurenine Hypothesis of Depression: Historical Overview and Recent Developments
Oxenkrug, G. F. (2013) · Current Drug Targets · doi:10.2174/1389450111314050002 · Cited by 163
Golia, M. T., Poggini, S., Alboni, S., Garofalo, S., Albanese, N. C., Viglione, A., Ajmone‐Cat, M. A., St-Pierre, A., Brunello, N., Limatola, C., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.07.003 · Cited by 161
Involvement of the kynurenine pathway in the pathogenesis of Parkinson's disease
Lim, C. K., Fernández-Gomez, F. J., Braidy, N., Estrada, C., Costa, C., Costa, S., Bessede, A., Fernandez-Villalba, E., Zinger, A., Herrero, M. T., et al. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.12.009 · Cited by 159
Zhu, C., Sawrey-Kubicek, L., Beals, E., Rhodes, C. H., Houts, H. E., Sacchi, R., & Zivkovic, A. M. (2020) · Nutrition Research · doi:10.1016/j.nutres.2020.03.005 · Cited by 153
Long, Y., Yang, Q., Xiang, Y., Zhang, Y., Wan, J., Liu, S., Li, N., & Peng, W. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104795 · Cited by 151
Self-citationAnderson, G., & Maes, M. H. J. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-014-0541-1 · Cited by 148
Effect of diet on serotonergic neurotransmission in depression
Shabbir, F., Patel, A. A., Mattison, C., Bose, S. K., Krishnamohan, R., Sweeney, E., Sandhu, S., Nel, W., Rais, A., Sandhu, R., et al. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2012.12.014 · Cited by 147
Talos, D. M., Fishman, R. E., Park, H., Folkerth, R. D., Follett, P. L., Volpe, J. J., & Jensen, F. E. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.20972 · Cited by 145
Hunt, C., Cordeiro, T. M. E., Suchting, R., de Dios, C., Cuellar, V. A., Soares, J. C., Dantzer, R., Teixeira, A. L., & Selvaraj, S. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.08.010 · Cited by 144
The kynurenine pathway and inflammation in amyotrophic lateral sclerosis
Chen, Y., Stankovic, R., Cullen, K. M., Meininger, V., Garner, B., Coggan, S., Grant, R., Brew, B. J., & Guillemin, G. J. (2010) · Neurotoxicity Research · doi:10.1007/s12640-009-9129-7 · Cited by 141
Miranda, A., Boegman, R. J., Beninger, R. J., & Jhamandas, K. H. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00655-0 · Cited by 139
Tryptophan Metabolites Are Associated With Symptoms and Nigral Pathology in Parkinson's Disease
Heilman, P. L., Wang, E. W., Lewis, M. M., Krzyżanowski, S., Capan, C. D., Burmeister, A. R., Du, G., Galvis, M. L. E., Brundin, P., Huang, X., et al. (2020) · Movement Disorders · doi:10.1002/mds.28202 · Cited by 134
Kynurenine emerges from the shadows – Current knowledge on its fate and function
Marszałek‐Grabska, M., Walczak, K., Gaweł, K., Wicha-Komsta, K., Wnorowska, S., Wnorowski, A., & Turski, W. A. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107845 · Cited by 128
Jauch, D., Urbańska, E. M., Guidetti, P., Bird, E. D., Vonsattel, J., Whetsell, W. O., & Schwarcz, R. M. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)00280-2 · Cited by 127
The kynurenine pathway in major depression: What we know and where to next
Brown, S. J., Huang, X., & Newell, K. A. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.05.018 · Cited by 119
Kynurenine metabolism in multiple sclerosis
Hartai, Z., Klivènyi, P., Janáky, T., Penke, B., Dux, L., & Vécsei, L. (2005) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2005.00442.x · Cited by 115
Suicidal patients are deficient in vitamin D, associated with a pro-inflammatory status in the blood
Grudet, C., Malm, J., Westrin, Å., & Brundin, L. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.08.016 · Cited by 112
Jee, H. J., Lee, S. G., Bormate, K. J., & Jung, Y.-S. (2020) · Nutrients · doi:10.3390/nu12103080 · Cited by 111
Inflammation: a mechanism of depression?
Han, Q.-Q., & Yu, J. M. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1439-3 · Cited by 107
The kynurenine pathway in chronic diseases: a compensatory mechanism or a driving force?
Joisten, N., Ruas, J. L., Braidy, N., Guillemin, G. J., & Zimmer, P. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.07.006 · Cited by 100
Kynurenine metabolism in plasma and in red blood cells in Parkinson's disease
Hartai, Z., Klivènyi, P., Janáky, T., Penke, B., László, A., & Vécsei, L. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.07.006 · Cited by 98
Fazio, F., Lionetto, L., Curto, M., Iacovelli, L., Copeland, C. S., Neale, S. A., Bruno, V., Battaglia, G., Salt, T. E., & Nicoletti, F. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.06.020 · Cited by 94
Tryptophan Metabolism and White Matter Integrity in Schizophrenia
Chiappelli, J., Postolache, T. T., Kochunov, P., Rowland, L. M., Wijtenburg, S. A., Shukla, D. K., Tagamets, M. A., Du, X. M., Savransky, A., Lowry, C. A., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.66 · Cited by 84
Forrest, C., Mackay, G. M., Stoy, N., Spiden, S. L., Taylor, R., Stone, T. W., & Darlington, L. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06442.x · Cited by 83
Souza, L. C., Jessé, C. R., Antunes, M. S., Ruff, J. R., Janner, D. E., Gomes, N. S., Donato, F., Giacomeli, R., & Boeira, S. P. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.03.002 · Cited by 83
Zheng, X., Hu, M., Zang, X., Fan, Q., Liu, Y., Che, Y., Guan, X., Hou, Y., Wang, G., & Hao, H. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.02.009 · Cited by 79
Endogenous Indole Pyruvate Pathway for Tryptophan Metabolism Mediated by IL4I1
Zhang, X., Gan, M., Li, J., Li, H., Su, M., Tan, D., Wang, S., Jia, M., Zhang, L., & Chen, G. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c03735 · Cited by 76
Silva‐Adaya, D., de la Cruz, V. P., Villeda‐Hernández, J., Carrillo-Mora, P. U., González-Herrera, I. G., Garcı́a, E., Colín-Barenque, L., Pedraza‐Chaverrí, J., & Santamarı́a, A. (2010) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2010.10.002 · Cited by 75
Electrophysiological characterisation of the actions of kynurenic acid at ligand-gated ion channels
Mok, M. H. S., Fricker, A.-C., Weil, A., & Kew, J. N. C. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.003 · Cited by 74
Endogenous kynurenic acid regulates extracellular GABA levels in the rat prefrontal cortex
Beggiato, S., Tanganelli, S., Fuxé, K., Antonelli, T., Schwarcz, R. M., & Ferraro, L. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.02.019 · Cited by 74
The immune-kynurenine pathway in social anxiety disorder
Butler, M., Long-Smith, C. M., Moloney, G. M., Mörkl, S., O’Mahony, S. M., Cryan, J. F., Clarke, G. A., & Dinan, T. G. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.10.020 · Cited by 70
Kynurenic acid downregulates IL-17/1L-23 axis in vitro
Elizei, S. S., Poormasjedi‐Meibod, M., Wang, X., Kheirandish, M., & Ghahary, A. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-2975-3 · Cited by 69
Tryptophan metabolites modify brain Aβ peptide degradation: A role in Alzheimer’s disease?
Maître, M., Klein, C., Patte‐Mensah, C., & Mensah‐Nyagan, A. G. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101800 · Cited by 69
Theofylaktopoulou, D., Ulvik, A., Midttun, Ø., Ueland, P. M., Vollset, S. E., Nygard, O. K., Hustad, S., Tell, G. S., & Eussen, S. J. P. M. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114514001858 · Cited by 68
Florensa-Zanuy, E., Garro-Martínez, E., Adell, A., Castro, E., Díaz, Á., Pazos, Á., MacDowell, K. S., Martín‐Hernández, D., & Pilar-Cuéllar, F. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114433 · Cited by 68
Research Advances in Cardio-Cerebrovascular Diseases of Ligusticum chuanxiong Hort.
Li, D., Long, Y., Yu, S., Shi, A., Wan, J., Wen, J., Li, X., Liu, S., Zhang, Y., Li, N., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.832673 · Cited by 68
Self-citationAnderson, G., & Maes, M. H. J. (2017) · International Journal of Tryptophan Research · doi:10.1177/1178646917691738 · Cited by 67
Behl, T., Kaur, I., Sehgal, A., Singh, S., Bhatia, S., Al‐Harrasi, A., Zengin, G., Bumbu, A. G., Andronie-Cioară, F. L., Nechifor, A. C., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136737 · Cited by 65
Emerging role for kynurenines in metabolic pathologies
Liu, J., Movassat, J., & Portha, B. (2018) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000529 · Cited by 62
Chen, B., Li, J., Xie, Y., Ming, X., Li, G., Wang, J., Li, M., Li, X., & Xiong, L. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112088 · Cited by 62
Self-citationTryptophan Catabolism and Inflammation: A Novel Therapeutic Target For Aortic Diseases
Ramprasath, T., Han, Y., Zhang, D., Yu, C., & Zou, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.731701 · Cited by 62
Gleeson, L. C., Ryan, K. J., Griffin, É. W., Connor, T. J., & Harkin, A. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.06.015 · Cited by 60
Gut Microbiota and Type 1 Diabetes Mellitus: The Effect of Mediterranean Diet
Calabrese, C. M., Valentini, A., & Calabrese, G. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2020.612773 · Cited by 58
Sodhi, R. K., Bansal, Y., Singh, R., Saroj, P., Bhandari, R., Kumar, B., & Kuhad, A. (2021) · NeuroToxicology · doi:10.1016/j.neuro.2021.03.009 · Cited by 57
Żarnowska, I., Wróbel‐Dudzińska, D., Tulidowicz-Bielak, M., Kocki, T., Mitosek‐Szewczyk, K., Ga̧sior, M., & Turski, W. A. (2019) · Seizure · doi:10.1016/j.seizure.2019.05.006 · Cited by 55
Interferon‐β affects the tryptophan metabolism in multiple sclerosis patients
Amirkhani, A., Rajda, C., Arvidsson, B., Bencsik, K., Boda, K., Seres, E., Markides, K. E., Vécsei, L., & Bergquist, J. (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2005.01041.x · Cited by 52
Human Activated T Lymphocytes Modulate IDO Expression in Tumors through Th1/Th2 Balance
Godin-Ethier, J., Pelletier, S., Hanafi, L., Gannon, P. O., Forget, M., Routy, J., Boulassel, M., Krzemien, U., Tanguay, S., Lattouf, J., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901004 · Cited by 51
Pettersson-Klein, A. T., Izadi, M., Ferreira, D. M. S., Červenka, I., Correia, J. C., Martínez-Redondo, V., Southern, M. R., Cameron, M. D., Kamenecka, T. M., Agudelo, L. Z., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.01.017 · Cited by 51
Linderholm, K. R., Andersson, A., Olsson, S. K., Olsson, E., Snodgrass, R., Engberg, G., & Erhardt, S. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.09.003 · Cited by 50
Kynurenine Pathway of Tryptophan Metabolism in Migraine and Functional Gastrointestinal Disorders
Fila, M., Chojnacki, J., Pawlowska, E., Szczepanska, J., Chojnacki, C., & Blasiak, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810134 · Cited by 50
Shao, H., Yang, Y., Mi, Z., Zhu, G.-X., Qi, A., Ji, W.-G., & Zhu, Z.-R. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.09.029 · Cited by 45
Ormstad, H., Bryn, V., Verkerk, R. M., Skjeldal, O. H., Halvorsen, B. L., Saugstad, O. D., Isaksen, J., & Maes, M. H. J. (2018) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527317666180720163221 · Cited by 45
Zhu, J., Hua, X., Yang, T., Guo, M., Li, Q., Xiao, L., Li, L., Chen, J., & Li, T. (2021) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-021-05066-w · Cited by 44
An emerging role for microglia in stress‐effects on memory
Sanguino‐Gómez, J., Buurstede, J. C., Abiega, O., Fitzsimons, C. P., Lucassen, P. J., Eggen, B. J. L., Lesuis, S. L., Meijer, O. C., & Krugers, H. J. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15188 · Cited by 43
Indoleamine 2,3 Dioxygenase as a Potential Therapeutic Target in Huntington’s Disease
Mazarei, G., & Leavitt, B. R. (2015) · Journal of Huntington s Disease · doi:10.3233/jhd-159003 · Cited by 41
Tufvesson‐Alm, M., Schwieler, L., Schwarcz, R. M., Goiny, M., Erhardt, S., & Engberg, G. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.06.003 · Cited by 39
Vitamin C and E Suppress Mitogen-Stimulated Peripheral Blood Mononuclear Cells in vitro
Winkler, C., Schroecksnadel, K., Schennach, H., & Fuchs, D. (2006) · International Archives of Allergy and Immunology · doi:10.1159/000096438 · Cited by 36
Central levels of tryptophan metabolites in subjects with bipolar disorder
Trepci, A., Sellgren, C. M., Pålsson, E., Brundin, L., Khanlarkhani, N., Schwieler, L., Landén, M., & Erhardt, S. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.11.018 · Cited by 36
Duda, W., Curzytek, K., Kubera, M., Connor, T. J., Fagan, E. M., Basta‐Kaim, A., Trojan, E., Papp, M., Gruca, P., Budziszewska, B., et al. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.05.039 · Cited by 32
Kainate and AMPA receptors in epilepsy: Cell biology, signalling pathways and possible crosstalk
Henley, J. M., Nair, J. D., Seager, R., Yucel, B. P., Woodhall, G. L., Henley, B. S., Talandyte, K., Needs, H. I., & Wilkinson, K. A. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108569 · Cited by 32
Weber, T., Vogt, M. A., Gartside, S. E., Berger, S. M., Luján, R., Lau, T., Herrmann, E., Sprengel, R., Bartsch, D., & Gass, P. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.332 · Cited by 31
Indoleamine-2,3-Dioxygenase 1 Deficiency Suppresses Seizures in Epilepsy
Deng, N., Deng, N., Hu, J., Hu, J., Xiong, Y., Hong, Y., 丁跃文, Ding, Y., Xiong, Y., Xiong, Y., et al. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.638854 · Cited by 30
Fujigaki, H., Mouri, A., Yamamoto, Y., Nabeshima, T., & Saito, K. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.02.001 · Cited by 29
Tryptophan Metabolism in Bipolar Disorder in a Longitudinal Setting
Fellendorf, F. T., Gostner, J. M., Lenger, M., Platzer, M., Birner, A., Maget, A., Queissner, R., Tmava‐Berisha, A., Pater, C. A., Ratzenhofer, M., et al. (2021) · Antioxidants · doi:10.3390/antiox10111795 · Cited by 29
Soichot, M., Vaast, A., Vignau, J., Guillemin, G. J., Lhermitte, M., Broly, F., & Allorge, D. (2013) · Alcohol and Alcoholism · doi:10.1093/alcalc/agt028 · Cited by 28
Kynurenine pathway metabolites: relevant to vitamin B-6 deficiency and beyond
Ciorba, M. A. (2013) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.072025 · Cited by 27
Urinary kynurenine as a biomarker for Parkinson’s disease
Bai, J.-H., Zheng, Y.-L., & Yu, Y.-P. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04589-x · Cited by 27
Alarcan, H., Chaumond, R., Emond, P., Bretagne, I. B., Lefèvre, A., Bakkouche, S. E., Veyrat‐Durebex, C., Vourc’h, P., Andres, C. R., Corcia, P., et al. (2021) · Biomolecules · doi:10.3390/biom11050691 · Cited by 27
Role of kynurenines in the neurotoxic actions of kainic acid
Behan, W. M. H., & Stone, T. W. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703250 · Cited by 26
The Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver Carcinogenesis
Shibata, Y., Hara, T., Nagano, J., Nakamura, N., Ohno, T., Ninomiya, S., Ito, H., Tanaka, T., Saito, K., Seishima, M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146279 · Cited by 25
Mice Lacking Brain‐Derived Serotonin Have Altered Swallowing Function
Haney, M. M., Sinnott, J., Osman, K. L., Deninger, I., Andel, E., Caywood, V., Mok, A., Ballenger, B., Cummings, K. J., Thombs, L. A., et al. (2019) · Otolaryngology · doi:10.1177/0194599819846109 · Cited by 25
Wang, Y., Chen, S., Tan, J., Gao, Y., Yan, H., Liu, Y., Yi, S., Xiao, Z., & Wu, H. (2021) · Brain and Behavior · doi:10.1002/brb3.2226 · Cited by 24
Klinkenberg, S., van den Borne, C. J. H., Aalbers, M. W., Verschuure, P., Kessels, A. G. H., Leenen, L. A. M., Rijkers, K., Aldenkamp, A. P., Vles, J. S. H., & Majoie, M. (2014) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.06.001 · Cited by 23
Alpha7 nicotinic‐N‐methyl‐D‐aspartate hypothesis in the treatment of schizophrenia and beyond
Koola, M. M. (2020) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2758 · Cited by 23
Li, C., Gan, L., Tan, Y. Y., Yan, M., Liu, X., Chang, Q., & Pan, R. (2021) · Journal of Proteomics · doi:10.1016/j.jprot.2021.104190 · Cited by 22
El‐Sewedy, S. M., Abdel‐Tawab, G. A., El‐Zoghby, S. M., Zeitoun, R., Mostafa, M. H., & Shalaby, S. M. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90178-6 · Cited by 16
Zarzecki, M. S., Souza, L. C., Giacomeli, R., Silva, M. R. P., Prigol, M., Boeira, S. P., & Jessé, C. R. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03144-6 · Cited by 13
Effect of Vitamins on Production of L-Tryptophan in Escherichia coli.JN8
Xiu-pin, L. (2013) · Journal of Food Science and Biotechnology · Cited by 1
Song, H., Wu, Z. H., Chaoketu, S., Luo, T., & Zhao, J. (2019) · 国际医药卫生导报 · doi:10.3760/cma.j.issn.1007-1245.2019.23.004 · Cited by 1
孔德文, Dewen, K., 于子茹, Zi-ru, Y., 周启蒙, Zhou, Q., 杜冠华, & Du, G. (2020) · doi:10.16438/j.0513-4870.2020-0677 · Cited by 1
Research progress of relationship between kainate receptors and neurodegenerative diseases
Yuan, L. (2014) · Chinese Journal of New Clinical Medicine · Cited by 1
Flagged first, then by citations
Research works printed but not linked: 22
- Lu, 2021, Nano-aromatic drugs for the treatments of neuropsychiatric disorders: University of Chinese academy of sciences
- Zhang, 2019, Advances in the regulation of tryptophan on animal physiological function, Special Wild Economic Anim Plant Res, 41, 10.16720/j.cnki.tcyj.2019.01.023 · DOI
- Qin, 2019, Research progress of tryptophan-kynurenine metabolic pathways and neurodegenerative diseases with intervention of traditional Chinese medicine, Tianjin J Traditional Chin Med, 36, 10.11656/j.issn.1672-1519.2019.10.22 · DOI
- Kong, 2012, Tryptophan / kynurenine metabolic pathway and cardiovascular disease, Chin J Hypertension, 20, 10.16439/j.cnki.1673-7245.2012.05.010 · DOI
- Li, 2014, Research of the exchange of blood serum Kyn/Trp ratio in post-hypertensive disorder complicating pregnancy
- Wang, 2016, Abnormal uric acid metabolic pathway and central nervous system diseases in dogs, Prog Physiol Sci, 47
- Liu, 2021, Effect of aerobic exercise on hippocampal neuroinflammation and improvement of NF-κB,TNF-α/IDO/5-HT signal pathway against in CUMS depressive mice, Chin J Immunol, 37, 10.3969/j.issn.1000-484X.2021.13.006 · DOI
- Yu, 2018, The research of neuroinflammatory-mediated exercise regulating the mechanism of alzheimer's disease, J Nanjing Sports Institute, 1, 33, 10.15877/j.cnki.nsin.2018.04.006 · DOI
- Wei, 2020, Vitamin d:a potential new approach to premature ejaculation research and treatment, Chin J Hum Sexuality, 29, 10.3969/j.issn.1672-1993.2020 · DOI
- Li, 2017, Effects of peiyuan jieyu formula on TRP-KYN metabolic pathway and its neuron protection mechanism in depressed rats induced by glucocorticoid, J Beijing Univ Traditional Chin Med, 40, 10.3969/j.issn.1006-2157.2017.12.008 · DOI
- Tang, 2019, Advances in research on relationship between kynurenine pathway and type 2 diabetes mellitus, Chin J Pathophysiol, 35, 10.3969/j.issn.1000-4718.2019.10.028 · DOI
- Liu, 2022, Progress in studies of glutamate-glutamine cycle in the pathogenesis of depression, Pharm Today, 32, 10.12048/j.issn.1674-229X.2022.03.008 · DOI
- Zhang, 2018, Research progress of NMDA receptor related antidepressants, Chin Pharmacol Bull, 34, 1, 10.3969/j.issn.1001-1978.2018.01.001 · DOI
- Huang, 2018, Research progress in targeted antagonists of NMDA receptor, Prog Physiol Sci, 49, 10.3969/j.issn.0559-7765.2018.03.011 · DOI
- Yan, 1995, Effects of stress on behavior and glutamate content in some brain regions of rats, Acta Psychologica Sin
- Qin, 2021, Progress in research on signal pathway related to antidepressant action of ketamine, Chin Pharm J, 56, 10.11669/cpj.2021.22.002 · DOI
- Yan, Research progress on the role of CD4+T cell polarization in inflammatory diseases, Chin J Immunol, 1
- Fan, 2018, Tryptophan metabolites regulate Th17/Treg differentiation to alleviate airway inflammation in asthmatic mice receiving allergen-specific immunotherapy, J Army Med Univ, 40, 10.16016/j.1000-5404.201709229 · DOI
- Liu, 2022, Effects of tryptophan hydroxylase 2 gene knockout on male rat behavior, J Northwest A F University(Natural Sci Edition), 50, 17, 10.13207/j.cnki.jnwafu.2022.04.003 · DOI
- Guo, 2021, Research progress on pathological mechanism and treatment of amyotrophic lateral sclerosis, Modern Chin Med, 41, 6, 10.13424/j.cnki.mtcm.2021.06.002 · DOI
- Lv, 2020, Research progress of kynuren ine pathway in alzheime's disease, J Hainan Med Univ, 26, 712, 10.13210/j.cnki.jhmu.20200212.007 · DOI
- Fu, 2018, Role of tryptophan-2, 3-dioxygenase in central nervous system diseases and potential for associated therapeutic strategies, Chin J Comp Med, 28, 10.3969/j.issn.1671-7856.2018.10.020 · DOI
Cited by
Sorted by citations
Mhanna, A., Martini, N., Hmaydoosh, G., Hamwi, G., Jarjanazi, M., Zaifah, G., Kazzazo, R., Mohamad, A. H., & Alshehabi, Z. (2024) · Medicine · doi:10.1097/md.0000000000037114 · Cited by 144
NAD metabolism: Role in senescence regulation and aging
Chini, C. C. S., Cordeiro, H. S., Tran, N. L. K., & Chini, E. N. (2023) · Aging Cell · doi:10.1111/acel.13920 · Cited by 148
Modulation of immunity by tryptophan microbial metabolites
Li, S. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1209613 · Cited by 104
Yang, J., Liang, J., Hu, N., He, N., Liu, B., Liu, G., & Qin, Y. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70091 · Cited by 109
Sharma, S., Chawla, S., Kumar, P., Ahmad, R., & Verma, P. K. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149123 · Cited by 103
Metadata
- Authors
- Li, D., Yu, S., Long, Y., Shi, A., Deng, J., Ma, Y., Wen, J., Li, X., Liu, S., Zhang, Y., Wan, J., Li, N., & Ao, R.
- Affiliations
- Chengdu University of Traditional Chinese Medicine (CN)
- Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital (CN)
- Corresponding author
- Li, Nan
- Ao, Rui
- ORCID
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2022-09-08
- Volume
- 13
- Pages
- 985378-985378
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC9496178
- OpenAlex
- W4295865246
- Cited by
- 129
- References
- 136
- Citations by year
- 2026: 27 · 2025: 52 · 2024: 32 · 2023: 18
- FWCI
- 1.93
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Jiangxi University of Traditional Chinese Medicine (zdsys-202107)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- tryptophan metabolism, tryptophan catabolites, neurological disorders, mental illness, Alzheimer's disease, depression, excitotoxicity, neuroinflammation, oxidative stress, mitochondrial damage, gut microbiota, glucocorticoids, aging, glutamate, GPR35, nicotinic acetylcholine receptors, aryl hydrocarbon receptor, dopamine
- MeSH terms
- Mental Disorders, Dopamine, Glucocorticoids, Humans, Receptors, Nicotinic, Tryptophan, Vitamins, Receptors, Aryl Hydrocarbon, Glutamic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review